Survival probabilities for HIV infected patients through semi-Markov processes
References
- Barbu V.S., Limnios N. (2008):Semi-Markov Chains and Hidden Semi-Markov Models Toward Applications: Their Use in Reliability and DNA Analysis. Lecture Notes in Statistics N° 191, Springer, New York. DOI: 10.1007/978-0-387-73173-5.
- Brookmeyer R., Gail M.H. (1994): AIDS Epidemiology: a Quantitative Approach. Oxford University Press, New York.
- Centres for Disease Control and Prevention (1993): Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recommendations and Reports, 41 N° RR-17: 1-19
- Corradi G., Janssen J., Manca R. (2004):Numerical treatment of homogeneous semi- Markov processes in transient case-a straightforward approach. Methodology and Computing in Applied Probability 6: 233-246.
- D’Amico G., Di Biase G., Janssen J., Manca R. (2011):HIV Evolution: A Quantification of the Effects Due to Age and to Medical Progress. Informatica 22 (1): 27-42.
- Davidov O. (1999): The steady state probabilities for a regenerative semi-Markov processes with application to prevention and screening. Applied Stochastic Models and Data Analysis 15: 55-63.
- Davidov O., Zelen M. (2000): Designing cancer prevention trials: a stochastic approach., Statistics in Medicine 19: 1983-1995.
- Di Biase G., D’Amico G., Di Girolamo A., Janssen J., Iacobelli S., Tinari N., Manca R. (2007a): Homogeneous semi-Markov model for predicting the HIV disease evolution: a case study. Far Edst. J. Math. Sci. (FJMS) 27: 89-109.
- Di Biase G., D’Amico G., Di Girolamo A., Janssen J., Iacobelli S., Tinari N., Manca R. (2007b):A Stochastic Model for the HIV/AIDS Dynamic Evolution. Mathematical problem in Engineering Art. ID 65636, 14 pages. DOI: 10.1155/2007/65636.
- Di Biase G., D’Amico G., Janssen J., Manca R. (2009): Patient’s Age Depending HIV/AIDS Evolution Analysis by means of a Non Homogeneous Semi-Markov Model. Advances and Applications in Statistics 11: 199-215. ISSN: 0972-3617.
- Fischl M.A., Reichmann D.D., Grieco M.H. et al. (1987): The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. A double blind placebo-controlled trial. New England Journal of Medicine 317: 185-191.
- Foucher Y., Mathieu E., Saint-Pierre P., Durand J.F., Daurès J.P. (2005): A semi- Markov model based on generalized Weibull distribution with an illustration for HIV disease. Biometrical Journal 47: 825-833.
- Foucher Y. (2007): Modèles semi-markoviens: Application à l'analyse de l'évolution de pathologies chroniques.Doctoral dissertation, Université de Montpellier 1
- Goedert J.J. (1990): Prognostic markers for AIDS. Annals of Epidemiology 1: 129-139.
- Goshu A.T., Dessie Z.G. (2013): Modelling Progression of HIV/AIDS Disease Stages Using Semi-Markov Processes. Journal of Data Science 11: 269-280.
- Howard R.A. (1971a): Dynamic Probabilistic Systems, Markov Models. John Wiley & Sons Vol. 1, New York.
- Howard R.A. (1971b): Dynamic Probabilistic Systems, Semi-Markov and Decision Processes. John Wiley & Sons Vol. 2, New York.
- Iosifescu Manu A. (1972): Non homogeneous semi-Markov processes, Stud. Lere. Mat. 24: 529-533.
- Jaffe H.W., Lifson A.R. (1988): Acquisition and transmission of HIV, Infectious Diseases Clinic of North America 2: 299-306.
- Janssen J., Manca R. (2006): Applied Semi-Markov Processes. Springer, New York.
- Joly P., Commenges D. (1999): A penalized likelihood approach for a progressive three-state model with censored and truncated data: application to AIDS. Biometrics 55: 887-890.
- Lagakos S.W., Sommer C.J., Zelen M. (1978): Semi-Markov models for partially censored Data. Biometrika 65: 311-317.
- Levy P. (1954): Processus semi-markoviens. Proceedings of the International Congress of Mathematicians 3: 416-426, Erven P. Noordhoff N.V., Groningen, The Netherlands.
- Levy J.A. (1993): Pathogenesis of human immunodeficiency virus infection. Microbiological Reviews 57: 183-289.
- Longini I.M., Clark J., Gardner W.S., Brundage J. (1991):The dynamics of CD4+ T lymphocyte decline in HIV infected individuals: A Markov modelling approach. Journal of Acquired Immunodeficiency Syndromes 4: 1141-1147.
- Marshall A.H., Shaw B., McClean S.I. (2007): Estimating the costs for a group of geriatric patients using the Coxian phase-type distribution. Statistics in Medicine 26: 2716-2729.
- Satten G.A., Sternberg M.R. (1999): Fitting semi-Markov models to interval-censored data with unknown initiation times. Biometrics 55: 507-513.
- Smith W.L. (1955): Regenerative stochastic processes. Proceedings of the Royal Society of London Series A. 232: 6-31.
- Sternberg M.R., Satten S.A. (1999): Discrete-time nonparametric estimation for semi- Markov models of chain-of-events data subject to interval-censoring and truncation. Biometrics 55: 514-522.
- Sweeting M.J., De Angelis D., Aalen O.O. (2005): Bayesian back-calculation using a multi-State model with application to HIV. Statistics in Medicine 24: 3991-4007.
- Tsiatis A.A., Dafni U., De Gruttola V. et al. (1992): The relationship of CD4 counts over time to survival of patients with AIDS: Is CD4 a good surrogated marker? Jewell N., Dietz K. and Farewell V (eds.), AIDS Epidemiology: Methodological Issues, Boston, Birkhauser: 257-274.
- UNAIDS/WHO AIDS Epidemic Update December 2006 (2006): available at http://www.unaids.org/en/HIV_data/epi2006/default.asp.
DOI: https://doi.org/10.2478/bile-2014-0002 | Journal eISSN: 2199-577X (formerly 1896-3811) | Journal ISSN: 1896-3811
Language: English
Page range: 13 - 36
Published on: Jun 6, 2014
Published by: Polish Biometric Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2014 Giovanni Masala, Giuseppina Cannas, Marco Micocci, published by Polish Biometric Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.